The study on renal excretion drug dosage adjustment by point of care test in community pharmacy

The study on renal excretion drug dosage adjustment by point of care test in community pharmacy - The study on proper use of medicine by point of care test in community pharmacy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024171

Enrollment

100

Registered

2016-10-01

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster, Chronic Kidney disease

Interventions

Serum creatinine point of care testing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients over 65 and/or had suspection of renal insufficiency The patients are prescribed aciclovir, valaciclovir, or famciclovir

Exclusion criteria

Exclusion criteria: Dialysis patient The patients taking anticoagulants The patients are prone to bleeding The patients who are unable to self-collect the blood sample

Design outcomes

Primary

Measure	Time frame
The number of avoidance of renally excreted drugs overdose	—

Secondary

Measure	Time frame
Reduction of drug cost Frequency of adverse drug event	—

Countries

Japan

Contacts

Public ContactYuki Kondo

Graduate School of Pharmaceutical Sciences, Kumamoto University Department of Clinical Chemistry and Informatics

ykondo@kumamoto-u.ac.jp096-371-4559

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026